Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
This entry represents a pseudogene with sequence similarity to the protein-coding gene DnaJ homolog, subfamily A, member 2 (DNAJA2), a member of the Hsp40/DnaJ protein family that acts as a co-chaperone with Hsp70 proteins and has roles in protein folding and cellular stress response[1][2]. Pseudogenes are generally considered nonfunctional remnants of genes, though in some cases may be transcribed into RNA and exert regulatory effects, such as through endogenous small interfering RNA pathways[3]. There is no evidence that this pseudogene encodes a functional protein or that it serves as a canonical molecular target in drug discovery or clinical diagnostics.
None (pseudogenes are not protein targets of drugs)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on pseudogene similar to part of DnaJ homolog, subfamily A, member 2 (DNAJA2) (None).